Certara Inc
Certara Inc (CERT) Historical Volatility
CERT's 30 day historical volatility is 52.85%, in the 55th percentile of readings over the past year. This is an average percentile, meaning Certara Inc shares have moved roughly in line with their typical range. CERT's 30 day implied volatility sits at 144.84%, with an IV Rank of 45.24%, leaving IV 91.99 points above historical volatility. This means options are pricing in more movement than the stock has actually delivered, as of Nov 2, 2026.
Read more
Tracking CERT historical volatility helps you see how much Certara Inc's stock price has actually moved, giving you a baseline for whether option premiums look fair, cheap, or expensive. While implied volatility shows what the market expects, CERT's HV, also known as realized volatility, shows what actually happened. Use our scanner to monitor CERT 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of a stock's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. CERT's 30 day historical volatility, or CERT HV, is one of the most widely watched readings because it balances responsiveness with stability. Comparing CERT's HV to its implied volatility reveals the volatility risk premium. When IV sits well above HV, options are pricing in more movement than the stock has actually delivered, giving option sellers an edge. When HV runs hot relative to IV, options are pricing in less movement than the stock has delivered, and buyers may be underpaying for it.
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access.
Historical Volatility
Historical movement is near its typical level for the past year. Neither unusually calm nor unusually active.
As of Nov 2, 2026
As of Nov 2, 2026
As of Nov 2, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →